| pubmed-article:10852261 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10852261 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10852261 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:10852261 | lifeskim:mentions | umls-concept:C2826293 | lld:lifeskim |
| pubmed-article:10852261 | lifeskim:mentions | umls-concept:C2714264 | lld:lifeskim |
| pubmed-article:10852261 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10852261 | pubmed:dateCreated | 2000-10-11 | lld:pubmed |
| pubmed-article:10852261 | pubmed:abstractText | To clarify the clinical significance of anticentromere antibodies (ACA) in patients with systemic lupus erythematosus (SLE). | lld:pubmed |
| pubmed-article:10852261 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10852261 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10852261 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10852261 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10852261 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10852261 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:10852261 | pubmed:author | pubmed-author:NakanoMM | lld:pubmed |
| pubmed-article:10852261 | pubmed:author | pubmed-author:ItoSS | lld:pubmed |
| pubmed-article:10852261 | pubmed:author | pubmed-author:HasegawaHH | lld:pubmed |
| pubmed-article:10852261 | pubmed:author | pubmed-author:GejyoFF | lld:pubmed |
| pubmed-article:10852261 | pubmed:author | pubmed-author:KurodaTT | lld:pubmed |
| pubmed-article:10852261 | pubmed:author | pubmed-author:OhuchiYY | lld:pubmed |
| pubmed-article:10852261 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10852261 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:10852261 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10852261 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10852261 | pubmed:pagination | 1403-7 | lld:pubmed |
| pubmed-article:10852261 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:meshHeading | pubmed-meshheading:10852261... | lld:pubmed |
| pubmed-article:10852261 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10852261 | pubmed:articleTitle | Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. | lld:pubmed |
| pubmed-article:10852261 | pubmed:affiliation | Department of Medicine II, Niigata University School of Medicine, Japan. | lld:pubmed |
| pubmed-article:10852261 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10852261 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10852261 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10852261 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10852261 | lld:pubmed |
